Biliary Tract Cancer
📧 Sign up to get email alerts when something new happens for Biliary Tract Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-04-06Clinical Trial Update: Preventing Viral Pandemic Associated Risk of Cancer Death Using Less Invasive Diagnostic Tests- Liquid Biopsies
Completed clinical trial update evaluating the use of liquid biopsies to reduce cancer death risk during viral pandemics. The provided snipp…
-
CLINICAL_TRIALS research · 2025-04-06Clinical Trial Update: Extracellular RNA Markers of Liver Disease and Cancer
This ClinicalTrials.gov update reports on a Mayo Clinic-sponsored study investigating extracellular RNA markers in liver disease and cancer,…
-
CLINICAL_TRIALS research · 2025-04-02Clinical Trial Update: A Study of HRS-4642 Monotherapy or in Combination With Adebrelimab in the Treatment of Advanced Biliary Tract Tumors. [Phase 2]
Phase 2 clinical trial evaluating HRS-4642 as monotherapy or in combination with Adebrelimab for advanced biliary tract tumors; currently re…
-
CLINICAL_TRIALS trial_result · 2025-03-30Clinical Trial Update: Clinical Correlation Study Between Anomalous Pancreaticobiliary Ductal Junction and Malignant Tumors of the Biliary System and the Establishment of an AI-based Automated Recognition System
This completed clinical trial investigated the relationship between anomalous pancreaticobiliary ductal junction and malignant tumors of the…
-
CLINICAL_TRIALS research · 2025-03-30Clinical Trial Update: Study of TU2218 in Combination With KEYTRUDA®(Pembrolizumab) in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating TU2218 in combination with pembrolizumab (Keytruda) in patients with advanced solid tumors is currentl…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-03-30Clinical Trial Update: Neoadjuvant Tislelizumab, Gemcitabine, Cisplatin and S-1 for Resectable High-risk Cholangiocarcinoma [Phase 2]
This clinical trial update describes a Phase 2 neoadjuvant regimen of tislelizumab, gemcitabine, cisplatin, and S-1 for resectable high-risk…
-
CLINICAL_TRIALS other · 2025-03-25Clinical Trial Update: Monitoring of patIents With Microdialysis Following Pancreaticoduodenectomy [NA]
Trial update from Oslo University Hospital on monitoring patients with microdialysis after pancreaticoduodenectomy. The study is currently a…
-
CLINICAL_TRIALS research · 2025-03-06Clinical Trial Update: A Clinical Study of SHR-A1811 in the Treatment of HER2-positive Locally Advanced or Metastatic Biliary Tract Cancer [Phase 2]
Phase 2 clinical trial evaluating SHR-A1811 for HER2-positive biliary tract cancer (locally advanced or metastatic) is currently recruiting.
-
CLINICAL_TRIALS research · 2025-02-17Clinical Trial Update: CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative Chemotherapy Versus Immediate Resection in patIents With resecTable BiliarY Tract Cancers (BTC) at High Risk for Recurrence [Phase 2, Phase 3]
Clinical trial update for a Phase 2/3 study evaluating preoperative Cisplatin, Gemcitabine, and Nab-paclitaxel (GAP) versus immediate resect…
-
CLINICAL_TRIALS research · 2025-02-11Clinical Trial Update: Phase I/II Clinical Study to Evaluate VB15010 Tablets in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
Phase I/II trial update for VB15010 tablets in advanced solid tumors; the study is currently recruiting across multiple cancer types.
-
CLINICAL_TRIALS research · 2025-02-11Clinical Trial Update: Ambispective Cohort Study of Precision Medicine for Primary Hepatobiliary Cancer Based on Next-generation Sequencing
This clinical trial update describes an Ambispective Cohort Study using next-generation sequencing-guided precision medicine for primary hep…
-
CLINICAL_TRIALS trial_result · 2025-02-10Clinical Trial Update: Inetetamab Plus Chemotherapy ± PD-1/PD-L1 in HER2+ Advanced Biliary Cancer [Phase 4]
A Phase 4 clinical trial update describes inetetamab plus chemotherapy with optional PD-1/PD-L1 inhibition for HER2-positive metastatic bili…
-
CLINICAL_TRIALS research · 2025-02-07Clinical Trial Update: XNW27011 Study of Advanced Solid Tumor Subjects Who Failed Standard Therapies. [Phase 1, Phase 2]
Clinical trial update indicating an early-phase study of XNW27011 for multiple advanced solid tumors is currently recruiting.
-
CLINICAL_TRIALS research · 2025-02-05Clinical Trial Update: First-line Trastuzumab, Gemcitabine, Cisplatin and Nivolumab in Advanced HER2- Positive Biliary Tract Cancer: a Multicenter, Open-label, Single-arm Phase Ib/II Trial (HERBOT) [Phase 1, Phase 2]
A multicenter, open-label Phase Ib/II trial evaluating first-line trastuzumab with gemcitabine and cisplatin plus nivolumab in HER2-positive…
-
CLINICAL_TRIALS research · 2025-01-28Clinical Trial Update: Donafenib Combined With Capecitabine for Postoperative Adjuvant Therapy of Biliary Malignant Tumors With High-risk Recurrence Risk [Phase 2]
Phase 2 trial evaluating donafenib in combination with capecitabine as postoperative adjuvant therapy for biliary tract cancer with high rec…
-
CLINICAL_TRIALS research · 2025-01-28Clinical Trial Update: Olaparib With or Without Durvalumab for DDR Gene Mutated Biliary Tract Cancer Following Platinum-based Chemotherapy [Phase 2]
Phase 2 clinical trial investigating olaparib with or without durvalumab for biliary tract cancer with DNA damage repair mutations after pla…
-
CLINICAL_TRIALS research · 2025-01-28Clinical Trial Update: A Prospective Cohort Study of Patients with Hepatobiliary Cancer Treated with Immune Checkpoint Inhibitors
This is a prospective cohort study evaluating immune checkpoint inhibitors in hepatobiliary cancers. The trial is currently active but not r…
-
CLINICAL_TRIALS trial_result · 2025-01-27Clinical Trial Update: A Study of CTX-009 (ABL001) in Combination With Irinotecan or Paclitaxel in Advanced or Metastatic Solid Tumor Patients [Phase 1, Phase 2]
A phase 1/2 study of CTX-009 (ABL001) in combination with irinotecan or paclitaxel for advanced/metastatic solid tumors, including biliary t…
-
CLINICAL_TRIALS trial_result · 2025-01-27Clinical Trial Update: Adebrelimab With or Without SHR-8068 in Combination With Cisplatin Plus Gemcitabine as First-line Treatment in Patients With Advanced Biliary Tract Cancer [Phase 2]
This is an ongoing Phase 2 trial evaluating adebrelimab with or without SHR-8068 in combination with cisplatin and gemcitabine as first-line…
-
CLINICAL_TRIALS trial_result · 2025-01-22Clinical Trial Update: Combination Therapy With NC-6004 and Gemcitabine in Advanced Solid Tumors or Non-Small Cell Lung, Biliary and Bladder Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating NC-6004 (a cisplatin nanoparticle formulation) in combination with gemcitabine has completed testing i…
-
CLINICAL_TRIALS research · 2024-12-30Clinical Trial Update: Circulating Tumor Mitochondrial DNA (ct-mtDNA) As a Biomarker for Biliary Tract Cancer Recurrence Surveillance
A clinical trial is investigating whether circulating tumor mitochondrial DNA can serve as a biomarker to monitor recurrence in biliary trac…
-
CLINICAL_TRIALS research · 2024-12-27Clinical Trial Update: Adebrelimab Combined with Apatinib and Gemcitabine and Cisplatin (GP) First-line Treatment for Unresectable Biliary Tract Carcinoma [Phase 2]
Phase 2 trial evaluating the combination of Adebrelimab with Apatinib and Gemcitabine/Cisplatin as first-line therapy for unresectable bilia…
-
CLINICAL_TRIALS research · 2024-12-16Clinical Trial Update: A Single-arm, Open-label, Prospective Clinical Study of Surufatinib Combined With Immunotherapy and Chemotherapy for Unresectable or Metastatic Biliary Tract Cancer. [Phase 2]
A Phase 2, single-arm, open-label trial examining surufatinib in combination with immunotherapy and chemotherapy for unresectable or metasta…
-
CLINICAL_TRIALS research · 2024-12-12Clinical Trial Update: Diagnostic Value of Next-Generation Sequencing Analysis in Biliary Tract Tumours [NA]
This clinical trial registry entry describes a study evaluating the diagnostic value of next-generation sequencing analysis in biliary tract…
-
CLINICAL_TRIALS trial_result · 2024-12-09Clinical Trial Update: A Study Evaluating Safety, Pharmacokinetics, Pharmacodynamics, And Clinical Activity Of RO7119929 (TLR7 Agonist) In Participants With Unresectable Advanced Or Metastatic Hepatocellular Carcinoma, Biliary Tract Cancer, Or Solid Tumors With Hepatic Metastases [Phase 1]
Phase 1 study assessing safety, pharmacokinetics, pharmacodynamics, and preliminary clinical activity of RO7119929 (TLR7 agonist) in partici…